Healio

New pulsed field ablation catheter safe, effective for paroxysmal AF: First-in-human data

Please provide your email address to receive an email when new articles are posted on . AF ablation with a novel contact force-sensing pulsed field catheter was safe and acutely effective. Three-month ...
Healio

FDA approves next-gen pulsed field ablation catheter for paroxysmal atrial fibrillation

Please provide your email address to receive an email when new articles are posted on . The FDA approved a navigation-enabled ablation catheter for the treatment of ...
FierceBiotech

Kardium nets $104M for its spherical pulsed field ablation catheter

Shortly after announcing positive clinical trial data from its pulsed field ablation treatment for irregular heart rhythms, Kardium has more good news to share: the company has secured $104 million in ...
TCTMD

Higher Stroke Risk Seen With Pulsed-Field vs Radiofrequency Ablation

The absolute rate is still below 0.5%, in line with prior ablation studies, but the issue warrants monitoring, a researcher ...
FierceBiotech

Boston Scientific’s navigation-equipped pulsed field ablation catheter passes FDA

Boston Scientific collected a set of FDA green lights for an update to its pulsed field ablation system for atrial fibrillation, allowing it to combine cardiac mapping sensors and therapy delivery in ...
Seeking Alpha

Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation

HAYWARD, Calif.--(BUSINESS WIRE)-- Pulse Biosciences, Inc. (PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) ...
Seeking Alpha

The Medtronic Sphere-360™ Pulse Field Ablation (PFA) catheter, a new paradigm in single-shot ablation, demonstrates impressive results in treating paroxysmal atrial fibrillation

EHRA late-breaking data: Results highlight efficacy, safety, and durability of the novel PFA catheter that is fully integrated with Affera™ Mapping and Ablation System The Sphere-360 catheter was ...
Morning Overview on MSN

New catheter aims to improve arrhythmia treatment as clinical trials begin

For the roughly 6 million Americans living with atrial fibrillation, catheter ablation has become an increasingly common ...
Yahoo

Pulse Biosciences wins FDA approval to begin PFA catheter study

Add Yahoo as a preferred source to see more of our stories on Google. This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive ...
Medical Device and Diagnostic Industry (MD+DI)

Pulse Biosciences Data Shows Advantage in PFA Technology That Could Disrupt Billion Dollar AFib Market

Pulse Biosciences is positioning its nanosecond PFA technology as a game-changer in the competitive atrial fibrillation ...
Business Wire

Pulse Biosciences Announces Late-Breaking Data from its Nanosecond PFA 360° Cardiac Catheter System First-In-Human Feasibility Study Presented at the AF Symposium

MIAMI--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced the late-breaking ...
Business Wire

Pulse Biosciences’ nPulse™ Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or ...